Overall rank by patents
#8,785
of 49,997 tracked assignees
USPTO PatentsView assignee record - 36 granted patents across 37 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C08B (POLYSACCHARIDES; Derivatives Thereof).
The verdict
According to USPTO PatentsView, Dupont ranks #8,785 of 49,997 tracked US assignees by granted-patent volume, with 36 patents across 37 technology areas.
USPTO PatentsView assignee plate
Corpus R8785 · US Corporation #8,785 · 36 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Development Center for Biotechnology (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
AAC Optics (Changzhou) · near
45 score
DuPont Industrial… · this assignee
45 score
E R Squibb & Sons L… · near
45 score
Epos Group A/S · near
45 score
Festo & KG · near
45 score
3D Lighting… · lowest
7 score
What this shows Dupont's Innovation Score is 44.9/100 (top 24% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
DuPont Industrial Biosciences USA, LLC is a focused PatentsView assignee: 37 CPC subclasses with 66.7% of grants classified under C08B (POLYSACCHARIDES; Derivatives Thereof). Peak complete grant year is 2020 (25 grants) versus a trough of 1 in 2022. By volume, Dupont sits between Development Center for Biotechnology and Echelon Corporation.
From 2019–2021 to 2022–2024, DuPont Industrial Biosciences USA, LLC moved from 34 to 1 grants (0.03x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Development Center for Biotechnology
36 patents
Diehl AKO Stiftung & Co. KG
36 patents
DrFirst.com, Inc.
36 patents
Draeger Medical Systems, Inc.
36 patents
Dynacraft BSC, Inc.
36 patents
E2interactive, Inc.
36 patents
Encell Technology, Inc.
36 patents
Echelon Corporation
36 patents
DuPont Industrial Biosciences USA, LLC
36 patents
What this shows DuPont holds 36 patents at rank #8,785, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #8,785 in granted patent volume.
Other assignees with the most granted patents in DuPont's primary technology class.
Two PlainPatent-derived peer sets for DuPont, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (45 here).
Dupont's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
45 Top 24% higher than 76% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2019 | 3 | 8.3% |
| 2020 | 25 | 69.4% |
| 2021 | 6 | 16.7% |
| 2022 | 1 | 2.8% |
| 2025partial year | 1 | 2.8% |
Top 15 of 37 technology areas
Overall rank by patents
#8,785
of 49,997 tracked assignees
44.9 out of 100
What to do with this data
DuPont Industrial Biosciences USA, LLC's patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.